A Study of TRV130 for the Treatment of Pain After Abdominoplasty

Completed · Phase 2 · Has a placebo group

Conditions studied: Pain

In brief

The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain following abdominoplasty.

Key facts

Study ID

NCT02335294

Run by

Trevena Inc.

People needed

200

Starts

2014-12-01

Expected to finish

2015-08-01

Last updated by the study team

2020-09-16

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• >=18 and <=65 years of age.
• Plans to undergo an abdominoplasty procedure with no additional collateral procedures.
• Is able to understand and comply with the procedures and study requirements, and to provide written informed consent before any study procedure.

You may not qualify if…

• ASA Physical Status Classification System classification of P3 or worse.
• Has surgical or post-surgical complications.
• Has clinically significant medical conditions or history of such conditions that may interfere with the interpretation of efficacy, safety, or tolerability data obtained in the trial, or may interfere with the absorption, distribution, metabolism, or excretion of drugs.
• Has previously participated in another TRV130 clinical study.

Where it is running

• Study site — Pasadena, California, United States
• Study site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.